您的位置:易推广 > 生物试剂/抗体/细胞 > 生物制剂 > 克隆系统 > 上海凯博生物科技有限公司(武汉分公司) > 产品展示 > 抗体 > 国产抗体 > DR1 protein转录下调蛋白1抗体

产品展示

DR1 protein转录下调蛋白1抗体

点击次数:203发布时间:2012/12/5 14:32:26

DR1 protein转录下调蛋白1抗体

更新日期:2024/9/5 14:43:01

所 在 地:中国大陆

产品型号:BY-9055R

简单介绍:本公司经销DR1 protein,转录下调蛋白1抗体,克隆类型为polyclonal,宿主来源是Rabbit,DR1 protein转录下调蛋白1抗体可应用于WB、elisa、IP、IF、IHC等实验,欢迎垂询订购!

优质供应

详细内容

本公司经销DR1 protein,转录下调蛋白1抗体,克隆类型为polyclonal,宿主来源是Rabbit,DR1 protein转录下调蛋白1抗体可应用于WB、elisa、IP、IF、IHC等实验,欢迎垂询订购!

货号:BY-9055R
英文名称:Anti-DR1 protein
中文名称:转录下调蛋白1抗体
其他名称:名Dr1 protein;NC2;Negative cofactor 2 beta;Down regulator of transcription 1;Down regulator of transcription 1 TBP binding;Down-regulator of transcription 1;DR 1;Dr1;NC 2;NC2 beta;NC2-beta;NC2B_HUMAN;Negative co factor 2;Negative cofactor 2;Negative cofactor 2-beta;Protein Dr1;TATA binding protein associated phosphoprotein;TATA-binding protein-associated phosphoprotein.
抗体来源:Rabbit
克隆类型:polyclonal
蛋白分子量:predicted molecular weight: 20kDa
纯化方法:affinity purified by Protein A
交叉反应:hu, mo, rat
产品介绍:DR1, also known as NC2∫ (negative cofactor 2 subunit ∫), is a TFIID (TATA box-binding protein)-associated protein. DR1 localizes to the nucleus and contains an N-terminal histone fold motif, a TFIID-binding domain and an alanine and glutamine rich region. Via its histone fold motif, DR1 forms a heterodimer with NC2å (DRAP1) to comprise the conserved eukaryotic complex, NC2 (negative cofactor 2). The NC2 complex can both positively and negatively regulate transcription by RNA Pol II. More specifically, NC2 acts as a repressor of TATA-dependent transcription and acts as an activator for DPE-dependent transcription. NC2 represses RNA Pol II transcription by binding to TFIID and inhibiting association of the transcription factors TFIIA and TFIIB. NC2 activity is regulated by phosphorylation. Both subunits, NC2å and DR1, are phosphorylated in vivo.Subcellular Location : Nucleus

联系我们

联系人:王羽

点击查看联系方式

企业档案

  • 会员类型:免费会员
  • 工商认证: 【未认证】
  • 最后认证时间:
  • 法人:
  • 注册号:****
  • 企业类型:生产商
  • 注册资金:人民币**万

script>
在线咨询

提交